Skip to content

Dr. Greg Bristow,
Assistant Professor

Information about Dr. Greg Bristow at the University of Bradford.

School of Pharmacy & Medical Sciences
(Faculty of Life Sciences)
Email:
g.bristow@bradford.ac.uk
Telephone:
+44 1274 238048
Photo of Dr. Greg Bristow

Biography

  • 2018- Lecturer in Physiology & Pharmacology, School of Pharmacy and Medical Sciences, University of Bradford
  • 2016-2018 Postdoctoral Research Associate, Faculty of Health and Medicine, University of Lancaster
  • 2014-2016 Postdoctoral Research Fellow, College of Pharmacy, University of Illinois at Chicago, USA
  • 2011-2013 Postdoctoral Research Fellow, School of Biology, University of Leeds
  • 2007-2010 Doctoral thesis (DPhil), Molecular Neuropathology Group, University of Oxford
  • 2005-2007 Research Assistant, Molecular Neuropathology Group, University of Oxford
  • 2002-2005 Undergraduate degree, Medical Sciences, University of Birmingham

Research

I am interested in the mechanisms underpinning psychiatric and neurodevelopmental disorders. My most recent project was investigating the role of copy number variations (CNVs) at chromosome 16p11.2, and how these CNVs confer risk of schizophrenia and autism.

My previous projects include investigating the effect of prenatal stress on neurodevelopment and RNA editing, and examining the role of tyrosine hydroxylase in behavioural changes caused by Toxoplasma Gondii infection.

Publications

There are 7 publications involving or that are attributed to Dr. Greg Bristow.

Peer Reviewed Journal

Dr. Greg Bristow has 7 publication(s) listed under peer reviewed journal.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
Impaired emotional categorisation in young people at increased familial risk of depression. 2007 Neuropsychologia 45 Mannie ZN;Bristow GC;Harmer CJ;Cowen PJ; 0028-3932 10.1016/j.neuropsychologia.2007.05.016
Memory impairment in young women at increased risk of depression: influence of cortisol and 5-HTT genotype. 2009 Psychological Medicine 39 Mannie ZN;Barnes J;Bristow GC;Harmer CJ;Cowen PJ; 0033-2917 10.1017/S0033291708004248
Downregulation of the Central Noradrenergic System by Toxoplasma gondii Infection. 2019 Infection and Immunity 87 Alsaady I;Tedford E;Alsaad M;Bristow G;Kohli S;Murray M;Reeves M;Vijayabaskar MS;Clapcote SJ;Wastling J;McConkey GA; 1098-5522 10.1128/IAI.00789-18
Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype. 2009 Journal of Brain Research 1301 Bristow GC;Lane TA;Walker M;Chen L;Sei Y;Hyde TM;Kleinman JE;Harrison PJ;Eastwood SL; 1872-6240 10.1016/j.brainres.2009.08.090
Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? 2013 Journal of Experimental Biology 216 Webster JP;Kaushik M;Bristow GC;McConkey GA; 1477-9145 10.1242/jeb.074716
Toxoplasma gondii infection and behaviour - location, location, location? 2013 Journal of Experimental Biology 216 McConkey GA;Martin HL;Bristow GC;Webster JP; 1477-9145 10.1242/jeb.074153
Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. 2015 Schizophrenia Research 167 Bristow GC;Bostrom JA;Haroutunian V;Sodhi MS; 1573-2509 10.1016/j.schres.2015.01.025